Coverage of "Pharmaceuticals" on Cryptosearcher: the stories and the context behind them.
AstraZeneca’s Q2 revenue climbed 5% to $15.38 billion, with core earnings per share surging 18% to $2.63, beating analyst expectations despite trial setbacks.
July 27, 2026
